Mobosetinib/mobosetinib drug donation policy

Mobocertinib/Mobocertinib (Mobocertinib) is a targeted drug for the treatment of non-small cell lung cancer (NSCLC). The innovative drug Mobocertinib succinate capsules have been conditionally approved for marketing in accordance with the priority review and approval process of the National Medical Products Administration. In some cases, their drug donation policies vary by region and specific circumstances, and certain conditions usually need to be met in order to receive free drugs.

Some common conditions for drug donation policies may include that patients must meet the indications and be deemed suitable for use of the drug after a doctor's evaluation; patients must pay a certain fee, usually a part of the drug price, to compensate the pharmaceutical company's R&D and production costs; patients need to provide necessary diagnosis certificates, medical records, identification and other documents so that doctors can verify their eligibility; the number of donated drugs is usually limited, and may need to wait in line or meet certain conditions to obtain it. Some areas may offer long-term drug gift programs, such as philanthropic programs established in partnership with pharmaceutical companies to provide a long-term supply of drugs to specific patient groups.

The domestically marketed original drug Mobosetinib has not yet been included in medical insurance. The price of 40mg*112 pills per box is around 40,000 yuan, which is very expensive. The Hong Kong version of the original drug specification40mg*30 pills per box is priced at more than 7,000 yuan (the price may fluctuate due to exchange rates). Generic drugs of Mobotinib have also been put on the market for sale overseas. The drug ingredients are basically the same as those of the original drugs at home and abroad. For example, the production specifications of Laos Pharmaceutical Factory40mg*120 pills per boxThe pricemay be more than 4,000 yuan (the price may fluctuate due to the exchange rate), and the price is relatively cheap.